Funabashi, Japan

Takehito Mouri

This inventor holds 2 USPTO granted patents. Top assignees: Kaken Pharmaceutical Company, Ltd., Sagami Chemical Research Center. Active years: 1997-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takehito Mouri. Retrieved from https://idiyas.com/inventor/takehito-mouri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.5

ph-index = 1


Location History:

  • Chiba-ken, JP (1997)
  • Funabashi, JP (2000)

Company Filing History:


Years Active: 1997-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Takehito Mouri

Introduction

Takehito Mouri is a notable inventor based in Funabashi, Japan. He has made significant contributions to the field of chemical research, particularly in the development of innovative processes and derivatives. With a total of 2 patents to his name, Mouri's work has had a meaningful impact on the industry.

Latest Patents

Mouri's latest patents include a process for the preparation of 3-(substituted - 4-imino-oxazolidine-2-one derivatives. This innovative process showcases his expertise in chemical synthesis and his commitment to advancing the field.

Career Highlights

Throughout his career, Mouri has worked with esteemed organizations such as Sagami Chemical Research Center and Kaken Pharmaceutical Company, Ltd. His experience in these companies has allowed him to refine his skills and contribute to various research projects.

Collaborations

Mouri has collaborated with notable coworkers, including Kenji Hirai and Katsuyuki Masuda. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Takehito Mouri's contributions to the field of chemical research and his innovative patents highlight his role as a significant inventor. His work continues to inspire advancements in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…